Specific amino acids modulate the embryotoxicity of nickel chloride and its transfer to the rat embryo in vitro.
To investigate the effects of amino acids on the embryotoxicity and placental transfer of nickel chloride (NiCl2), Day 10 rat embryos were cultured in rat serum medium containing NiCl2 or 63NiCl2 (0.34 or 0.68 mM Ni), with or without L-histidine (2 mM), L-aspartic acid, glycine (2 or 8 mM), or L-cysteine (2 mM). After 26 hr, conceptuses were assessed for survival, growth and development, and malformations. The 63Ni contents of embryos and yolk sacs and the extent of 63Ni binding to the proteins of the culture medium were also determined. NiCl2 alone did not affect the embryonic development at 0.34 mM and caused growth retardation and brain and caudal abnormalities at 0.68 mM. Coincubation of L-histidine with 0.34 mM Ni increased Ni concentrations in embryonic tissues compared to 0.34 mM 63Ni alone, but did not elicit NiCl2 embryotoxicity. Coincubation of L-cysteine with 0.34 mM Ni elicited growth retardation and brain abnormalities caused by NiCl2 and increased yolk sac concentrations of 63Ni compared to 0.34 mM 63Ni alone. In contrast, coincubation of L-histidine, L-cysteine, or L-aspartic acid with 0.68 mM Ni reduced the growth retardation and the incidence and/or severity of brain defects caused by NiCl2 and decreased the concentrations of 63Ni in the yolk sacs, compared to 0.68 mM 63Ni alone. L-Histidine also reduced the percentage of NiCl2-elicited caudal defects. Coincubation with glycine did not NiCl2-elicited caudal defects. Coincubation with glycine did not affect the embryotoxic profile, nor the placental transfer of NiCl2. In the presence of L-histidine, L-cysteine, or L-aspartic acid, there was a shift of 63Ni binding from the high-molecular-weight proteins of the culture medium to the low-molecular-weight fraction. Thus, specific extracellular amino acids can modulate the embryotoxicity and placental transfer of NiCl2 in vitro. The pattern of this modulation is dependent on the concentration of NiCl2, as well as on the amino acid.
Saillenfait
A M
AM
Institut National de Recherche et de Sécurité, Vandoeuvre, France.
Payan
J P
JP
Sabate
J P
JP
Langonne
I
I
Fabry
J P
JP
Beydon
D
D
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D003545:Cysteine / Q000494:pharmacology; D004622:Embryo, Mammalian / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D005314:Embryonic and Fetal Development; D005260:Female; D006639:Histidine / Q000494:pharmacology; D009532:Nickel / Q000493:pharmacokinetics / Q000633:toxicity*; D009924:Organ Culture Techniques; D011247:Pregnancy; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
D000596:Amino Acids; D001224:Aspartic Acid; D006639:Histidine; C022838:nickel chloride; D009532:Nickel; D003545:Cysteine